Syros Pharmaceuticals, Inc(NASDAQ:SYRS) 
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in Ph...
Website: http://www.syros.com
Founded: 2011
Full Time Employees: 83
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.02
H 0.02
L 0.01
C 0.02
V 353,727
10EMA 0.02
20EMA 0.02
60EMA 0.02
120EMA 0.02
250EMA 0.02